Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

Peer review reports

Original Submission
17 Dec 2020	Submitted	Original manuscript
10 Feb 2021	Reviewed	Reviewer Report - Norah Abanmy
18 Apr 2021	Reviewed	Reviewer Report
19 Apr 2021	Reviewed	Reviewer Report
22 May 2021	Author responded	Author comments - Saowalak Turongkaravee
Resubmission - Version 2
22 May 2021	Submitted	Manuscript version 2
9 Jul 2021	Author responded	Author comments - Saowalak Turongkaravee
Resubmission - Version 3
9 Jul 2021	Submitted	Manuscript version 3
29 Aug 2021	Author responded	Author comments - Saowalak Turongkaravee
Resubmission - Version 4
29 Aug 2021	Submitted	Manuscript version 4
Publishing
14 Sep 2021	Editorially accepted
2 Oct 2021	Article published	10.1186/s12913-021-07025-8

Back to article page